The European Alliance for Personalised Medicine (EAPM) was launched in March 2012, and it brings together European healthcare experts and patient advocates involved with major chronic diseases.
The aim is to improve patient care by accelerating the development, delivery and uptake of personalised healthcare including personalised medicine and diagnostics. It is calling for the European Commission, the European Parliament and EU member states to help improve the regulatory environment so that Europe’s patients and citizens can have early access to personalised healthcare, and so that public health research is boosted.
Personalised medicine can change healthcare. It will help tailor healthcare solutions to the individual patient, instead of relying on a ‘one-size-fits-all’ approach. Healthcare services will increasingly deliver the right intervention to the right person at the right time, improving the outcomes for patients and cutting down unnecessary treatments.
Avenue de l'Armee 10
+32 4725 35 104
Login to display
|Ms Chiara Bernini||Account Admin|
|Maintaining Public Trust in use of Digital Health for health Science in a COVID ...||30 Jun 2020|
|EAPM Croatia Presidency Conference “Defining the healthcare ecosystem to deter...||24 Mar 2020|
|Forward together with Innovation: The importance of policy making in the era of ...||3 Dec 2019|
|Forward as one: Healthcare innovation and the need for policymaker engagement||9 Apr 2019|
|Personalising Your Health: A Global Imperative!||27 Nov 2017|
|EAPM 5th Annual Presidency Conference - “Innovation and Screening in Lung Canc...||28 Mar 2017|